SAGE - Sage Therapeutics Inc
IEX Last Trade
8.435
0.345 4.090%
Share volume: 531,209
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.09
0.35
4.27%
Summary score
22%
Profitability
20%
Dept financing
3%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.57%
Return on assets
-7.09%
Return on sales
-5469.04%
Return on invested capital
6.3%
Total debt ratio
7.28%
Debt ratio change over timeo
-0.96%
Current Ratio
17.6%
Quick Ratio
17.6%
Cash Position Ratio
16.89%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.13%
Return on assets
-13.71%
Return on sales
-2348.12%
Return on invested capital
153.34%
Total debt ratio
10.33%
Debt ratio change over timeo
-0.91%
Current Ratio
9.92%
Quick Ratio
9.92%
Cash Position Ratio
9.16%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-16.38%
Return on assets
-15.97%
Return on sales
-1286.11%
Return on invested capital
175.07%
Total debt ratio
9.9%
Debt ratio change over time
-0.94%
Current Ratio
9.95%
Quick Ratio
9.95%
Cash Position Ratio
9.37%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.38%
Return on assets
-104.18%
Return on sales
-2679.14%
Return on invested capital
-131.81%
Total debt ratio
-95.83%
Debt ratio change over time
-0.96%
Current Ratio
8.47%
Quick Ratio
8.47%
Cash Position Ratio
8.08%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SAGE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.57% | 15.05% | 35.64% | 7.13% |
| Return on assets | -7.09% | 2.88% | 3.13% | 5.53% |
| Return on sales | -5469.04% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 6.3% | 2.57% | 5.37% | 18.48% |
| Profitability | 9% | 45% | 66% | 80% |
| Total debt ratio | 7.28% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -0.96% | 326.95% | -8.44% | 1.18% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 9.92% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 9.92% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 9.16% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 3% | 6% | 15% |
| Short-term ratios | SAGE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.13% | 13.14% | 10.88% | 4.07% |
| Return on assets | -13.71% | 2.1% | 1.54% | 3.03% |
| Return on sales | -2348.12% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 153.34% | 1.95% | 2.74% | 9.55% |
| Profitability | 25% | 61% | 49% | 59% |
| Total debt ratio | 10.33% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -0.91% | 51.04% | -101.54% | 1.43% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 9.92% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 9.92% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 9.16% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 5% | 12% | 33% |